511509 — Vivo Bio Tech Share Price
- IN₹722.37m
- IN₹1.29bn
- IN₹454.51m
- 74
- 72
- 70
- 86
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.21 | ||
Price to Tang. Book | 1.36 | ||
Price to Free Cashflow | 5.88 | ||
Price to Sales | 1.57 | ||
EV to EBITDA | 6.22 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 11.6% | ||
Return on Equity | 12.41% | ||
Operating Margin | 25.29% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 553.52 | 517.75 | 513.91 | 522.3 | 454.51 | n/a | n/a | -4.03% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +65.3 | +22.66 | -63.23 | +14.97 | -15.25 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Vivo Bio Tech Limited is an India-based company, which is a comprehensive preclinical clinical research organization (CRO) serving pharmaceutical and biotech firms. It operates in the biotechnology segment. It provides integrated discovery, development & regulatory services to pharmaceutical, agrochemical, industrial chemical, vaccines, nutraceutical & medical device companies. The Company's services include in-Vivo and in-Vitro toxicity studies, pharmacological investigations, pharmacokinetic, toxicokinetic studies, genotoxicity screening and analytical services. It screens and assesses molecules for diverse pharmacological properties. In oncology, it designs syngeneic/xenograft models for anti-cancer agent evaluation. It customizes in-Vivo DMPK studies for rodent and non-rodent models to profile drug candidates. It provides both regulatory and non-regulatory IND-enabling preclinical development services.
Directors
- Kompella Sri Kalyan CFO
- M. Kalyan Ram EDR
- Karthik Allenkala SEC
- Tejomurthula Kuppambhotla NED
- Karopadi Nayak NED
- Alangudi Sankaranarayanan NED (76)
- Hariharan Ravindran IND
- Kunda Kalpana NID
- Mangipudi Ram NID
- K. Sunder NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 12th, 1987
- Public Since
- May 23rd, 1994
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Bombay Stock Exchange
- Shares in Issue
- 17,924,816

- Address
- 608 6Th Floor, HYDERABAD, 500034
- Web
- http://www.vivobio.com/
- Phone
- +91 4048199999
- Auditors
- P. Murali & Co.
Upcoming Events for 511509
Q1 2026 Vivo Bio Tech Ltd Earnings Release
Vivo Bio Tech Ltd Annual Shareholders Meeting
Similar to 511509
Indo US Bio-Tech
Bombay Stock Exchange
Jeevan Scientific Technology
Bombay Stock Exchange
Shree Ganesh Remedies
Bombay Stock Exchange
Transgene Biotek
Bombay Stock Exchange
Vanta Bioscience
Bombay Stock Exchange
FAQ
As of Today at 24:00 UTC, shares in Vivo Bio Tech are trading at IN₹40.30. This share price information is delayed by 15 minutes.
Shares in Vivo Bio Tech last closed at IN₹40.30 and the price had moved by -11.6% over the past 365 days. In terms of relative price strength the Vivo Bio Tech share price has underperformed the S&P BSE 100 Index by -18.1% over the past year.
There is no consensus recommendation for this security.
Find out moreVivo Bio Tech does not currently pay a dividend.
Vivo Bio Tech does not currently pay a dividend.
Vivo Bio Tech does not currently pay a dividend.
To buy shares in Vivo Bio Tech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹40.30, shares in Vivo Bio Tech had a market capitalisation of IN₹722.37m.
Here are the trading details for Vivo Bio Tech:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 511509
Based on an overall assessment of its quality, value and momentum Vivo Bio Tech is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vivo Bio Tech. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +13.33%.
As of the last closing price of IN₹40.30, shares in Vivo Bio Tech were trading +3.18% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Vivo Bio Tech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹40.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Vivo Bio Tech's management team is headed by:
- Kompella Sri Kalyan - CFO
- M. Kalyan Ram - EDR
- Karthik Allenkala - SEC
- Tejomurthula Kuppambhotla - NED
- Karopadi Nayak - NED
- Alangudi Sankaranarayanan - NED
- Hariharan Ravindran - IND
- Kunda Kalpana - NID
- Mangipudi Ram - NID
- K. Sunder - NID